Neuren Pharmaceuticals Limited
NURPF · OTC
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 H1 | August 28, 2026 | — | 20.72M | — | 0.05 | — |
| 2025 H2 | February 27, 2026 | 24.29M | 24.04M | 0.08 | 0.01 | — |
| 2025 H1 | August 27, 2025 | 18.53M | 18.59M | 0.08 | 0.08 | — |
| 2025 Q1 | May 7, 2025 | — | — | — | — | — |
| 2024 H2 | February 28, 2025 | 119.15M | 113.90M | 0.64 | 0.64 | — |
| 2024 Q3 | November 7, 2024 | — | — | — | — | — |
| 2024 Q2 | August 7, 2024 | — | — | — | — | — |
| 2023 H2 | February 29, 2024 | 115.06M | 112.53M | 0.57 | 0.67 | — |
| 2023 Q4 | January 31, 2024 | — | — | — | — | — |
| 2023 Q3 | October 20, 2023 | — | — | — | — | — |
| 2023 H1 | August 28, 2023 | — | — | — | — | — |
| 2023 Q2 | July 31, 2023 | — | — | — | — | — |
| 2023 Q1 | April 28, 2023 | — | — | — | — | — |
| 2022 H2 | February 23, 2023 | — | — | — | — | — |
| 2022 Q4 | January 30, 2023 | — | — | — | — | — |
| 2022 Q3 | October 27, 2022 | — | — | — | — | — |